Trump is back: Here’s what his initial actions mean for medtech

President Donald Trump has returned to office and swiftly enacted a series of executive orders that could impact the medtech industry.

These orders include withdrawing the U.S. from the World Health Organization (WHO), freezing regulatory actions pending review, and rescinding policies from the previous administration.

Here are the details of these Trump administration actions and their potential relevance to medtech:

Withdrawal from the WHO

One of Trump’s first executive orders formally initiates the withdrawal of the U.S. from WHO, a part of the United Nations that focuses on combatting global public health emergencies. In the executive order, the administration cited the organization’s handling of the COVID-19 pandemic, failure to adopt reforms, and perceived political bias.

Sign up for Blog Updates